Citace podle APA (7th ed.)

Taylor, P., Christensen, R., Moosavi, S., Selema, P., Guilatco, R., Fowler, H., . . . Haraoui, B. (2019). Real-world safety data from patients with rheumatic diseases treated with CT-P13, an infliximab biosimilar: An interim analysis from an observational study. BMJ Journals.

Citace podle Chicago (17th ed.)

Taylor, P., R. Christensen, S. Moosavi, P. Selema, R. Guilatco, H. Fowler, C. Bombardier, a B. Haraoui. Real-world Safety Data from Patients with Rheumatic Diseases Treated with CT-P13, an Infliximab Biosimilar: An Interim Analysis from an Observational Study. BMJ Journals, 2019.

Citace podle MLA (9th ed.)

Taylor, P., et al. Real-world Safety Data from Patients with Rheumatic Diseases Treated with CT-P13, an Infliximab Biosimilar: An Interim Analysis from an Observational Study. BMJ Journals, 2019.

Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..